Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Micelles01:30

Micelles

Micelle formation is an intricate process that hinges on the properties of amphiphilic or amphipathic molecules and the conditions of the system in which they are found. Amphiphilic molecules, which have both hydrophilic (water-attracting) and hydrophobic (water-repelling) parts, play a critical role in this process.In aqueous environments, these molecules arrange themselves such that their hydrophilic heads are turned towards the water phase, while their hydrophobic tails are oriented away...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
Modified-Release Drug Delivery Systems: Overview01:19

Modified-Release Drug Delivery Systems: Overview

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

siRNA based drug design, quality, delivery and clinical translation.

Nanomedicine : nanotechnology, biology, and medicine·2020
Same author

Efficient nanocarriers of siRNA therapeutics for cancer treatment.

Translational research : the journal of laboratory and clinical medicine·2019
Same author

MDM2 antagonist-loaded targeted micelles in combination with doxorubicin: effective synergism against human glioblastoma via p53 re-activation.

Journal of drug targeting·2019
Same author

Double-targeted polymersomes and liposomes for multiple barrier crossing.

International journal of pharmaceutics·2016
Same author

Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid.

Oncogene·2015
Same author

Hypoxia-targeted siRNA delivery.

Angewandte Chemie (International ed. in English)·2014

Related Experiment Video

Updated: Jul 18, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

Micellar nanocarriers: pharmaceutical perspectives.

V P Torchilin1

  • 1Department of Pharmaceutical Sciences and Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Mugar Building, Room 312, 360 Huntington Avenue, Boston, Massachusetts 02115, USA. v.torchilin@neu.edu

Pharmaceutical Research
|November 17, 2006
PubMed
Summary

Polymeric micelles, self-assembling nanoparticles, are effective carriers for poorly soluble drugs and imaging agents. Advanced designs like lipid-core and immunomicelles enhance drug delivery and targeting capabilities.

More Related Videos

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

Related Experiment Videos

Last Updated: Jul 18, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

Area of Science:

  • Nanotechnology
  • Materials Science
  • Pharmaceutical Sciences

Background:

  • Micelles are self-assembling nanoparticles with hydrophobic cores and hydrophilic shells, effectively used as carriers for water-insoluble drugs.
  • Amphiphilic copolymers are increasingly utilized for creating stable, biocompatible polymeric micelles with broad drug solubilization capacity.
  • Lipid-core micelles, formed by conjugating copolymers with lipids like PEG-PE, represent a significant advancement in micelle technology.

Purpose of the Study:

  • To review recent advancements in the application of polymeric micelles as pharmaceutical carriers.
  • To highlight the potential of micelles, including lipid-core and immunomicelles, as imaging agents.
  • To discuss various strategies for targeted drug delivery using micelles, such as the EPR effect and ligand conjugation.

Main Methods:

  • Self-assembly of amphiphilic copolymers into micelles.
  • Formulation of lipid-core micelles using copolymer-lipid conjugates (e.g., PEG-PE).
  • Development of targeted micelles through strategies like the EPR effect, stimuli-responsive designs, and ligand attachment (e.g., monoclonal antibodies for immunomicelles).

Main Results:

  • Polymeric micelles demonstrate high in vitro and in vivo stability and good biocompatibility.
  • Drug-loaded micelles are progressing through preclinical and clinical trials for various applications.
  • Micelles can be engineered for targeted delivery and imaging by incorporating reporter groups or specific ligands.

Conclusions:

  • Polymeric micelles, particularly lipid-core and immunomicelles, offer versatile platforms for drug delivery and biomedical imaging.
  • Targeting strategies significantly enhance the efficacy of micelle-based therapeutics.
  • Continued research into micelle design promises improved pharmaceutical carriers and diagnostic tools.